References
Cuschieri A, Weeden S, Fielding J et al (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MCR randomized surgical trial. Br J Cancer 79:1522–1530
Bonenkamp JJ, Hermans J, Sasako M et al (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340:908–914
Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820
Csendes A, Burdiles P, Rojas J et al (2002) A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 with gastric carcinoma. Surgery 131:401–407
Siewert JR, Bötcher K, Stein HJ et al (1998) Relevant prognostic factors in gastric cancer. Ann Surg 228:449–461
Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730
Manterola C, Torres R, Burgos L et al (2006) Calidad metodológica de un artículo de tratamiento de cáncer gástrico adoptado como protocolo por algunos hospitales chilenos. Rev Med Chile 134:920–926
Cunningham D, Allum WH, Stenning S et al (2006) Perioperative chemotherapy versus surgery alone for respectable gastroesophageal cancer. N Engl J Med 355:11–20
Ajani JA, Mansfield PF, Crane CH et al (2005) Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol 23:1237–1244
Lordick F, Ott K, Krause BJ et al (2007) PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 8:797–805
Yu W, Whang I, Chung HY et al (2001) Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg 25:985–990
Lenz HJ, Lee FC, Haller DG et al (2007) Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated advanced gastric carcinoma in a multicenter phase II study. Cancer 109:33–40
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lacueva, F.J., Oliver, I. Perioperative and adjuvant treatments for gastric cancer. Definitive new standards of care or are we still on the way?. Clin Transl Oncol 9, 747–748 (2007). https://doi.org/10.1007/s12094-007-0134-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-007-0134-0